Given the growing emphasis on molecular classification in endometrial cancer, markers such as POLE mutations, p53 abnormality, and mismatch repair (MMR) status are increasingly recognized as predictive of recurrence and lymphatic spread. The gene discussed is TP53; the disease is endometrial cancer.